You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海爾生物(688139.SH):一季度新產品方案佈局加快
格隆匯 06-08 10:00

格隆匯6月8日丨有投資者向海爾生物(688139.SH)提問:請問公司是否可以介紹下在新方案方面的進展?

海爾生物回覆:公司堅持技術引領戰略,一季度新產品方案佈局加快。面向科研和製藥用户,公司的自動化樣本庫、生物培養、離心製備、實驗室耗材等系列品類不斷細分豐富,逐漸成為增長新動力;面向醫院用户,隨着厚宏智能科技併購落地,用藥自動化方案矩陣進一步完善,市場競爭力持續提升;面向公共衞生用户,AI自動化疫苗工作站、數字化公共衞生體檢等方案湧現,在方案升級和場景延伸上繼續發力;面對血/漿站用户,海爾血技(重慶)二期工廠投產,產能提升的同時也支持了血液安全新品類的拓展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account